Breaking News

Has no content to show!

Pharmaceutical News

OTC medicines: Drug advisory body gives in-principle approval

Soon, pharmacists will be able to dispense drugs for minor conditions without a doctor’s prescription.


Dr Reddy’s says German regulator makes 6 observations on its Duvvada unit

Dr. Reddy’s Laboratories said on Friday a German regulator has made six major observations about its Duvvada drug making facility in the southern Indian state of Andhra Pradesh,


Aurobindo Pharma in talks to buy Shreya Life Sciences’s Russia business

Aurobindo Pharma Ltd is in talks to buy the Russia business of Mumbai-based Shreya Life Sciences Pvt. Ltd in a deal potentially valued between $80 million and $100 million, two people aware of the discussions said on condition of anonymity.


Investors file class action suit against Dr. Reddy’s in US court

Dr. Reddy’s Laboratories Ltd said on Monday that some investors had filed a class action lawsuit against the drug maker in the US District Court of New Jersey, alleging violation of US federal securities laws.Shares of the Hyderabad-based drug maker fell 2.8% on the announcement in intraday trading but recouped some of the loss later.


About Us

Wealthbuilder.co.in is design and developed to provide quality trading and investment recommendations & guidance for trading in the Indian Stock Market.

Wealthbuilder.co.in attempts to deliver a value driven service to the investing community by bringing together a powerful mix of expert advice, stock news and analysis.

Contact Information


Brand Partners